Article abstract


Nature Genetics 39, 41 - 51 (2006)
Published online: 17 December 2006 | doi:10.1038/ng1935

Integrative molecular concept modeling of prostate cancer progression

Scott A Tomlins1,8, Rohit Mehra1,2,8, Daniel R Rhodes1,2,3,8, Xuhong Cao1, Lei Wang1, Saravana M Dhanasekaran1, Shanker Kalyana-Sundaram1, John T Wei2,4, Mark A Rubin5,6, Kenneth J Pienta2,4,7, Rajal B Shah1,2,4 & Arul M Chinnaiyan1,2,3,4


Despite efforts to profile prostate cancer, the genetic alterations and biological processes that correlate with the observed histological progression are unclear. Using laser-capture microdissection to isolate 101 cell populations, we have profiled prostate cancer progression from benign epithelium to metastatic disease. By analyzing expression signatures in the context of over 14,000 'molecular concepts', or sets of biologically connected genes, we generated an integrative model of progression. Molecular concepts that demarcate critical transitions in progression include protein biosynthesis, E26 transformation-specific (ETS) family transcriptional targets, androgen signaling and cell proliferation. Of note, relative to low-grade prostate cancer (Gleason pattern 3), high-grade cancer (Gleason pattern 4) shows an attenuated androgen signaling signature, similar to metastatic prostate cancer, which may reflect dedifferentiation and explain the clinical association of grade with prognosis. Taken together, these data show that analyzing gene expression signatures in the context of a compendium of molecular concepts is useful in understanding cancer biology.

Top
  1. Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
  2. Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
  3. Bioinformatics Program, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
  4. Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
  5. Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  6. Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  7. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
  8. These authors contributed equally to this manuscript.

Correspondence to: Arul M Chinnaiyan1,2,3,4 e-mail: arul@umich.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Higher order structure in the cancer transcriptome and systems medicine

Molecular Systems Biology News and Views (13 Mar 2007)

TMPRSS2-ERG and PTEN loss in prostate cancer

Nature Genetics News and Views (01 May 2009)


Extra navigation

Subscribe to Nature Genetics

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT